Free Trial

Reckitt Benckiser Group's (RKT) "Buy" Rating Reaffirmed at UBS Group

Reckitt Benckiser Group logo with Consumer Defensive background

Key Points

  • UBS Group has reaffirmed a "buy" rating for Reckitt Benckiser Group (RKT) with a target price of GBX 7,700, suggesting a potential upside of 32.26%.
  • Despite UBS's positive outlook, other analysts have mixed opinions, with Berenberg Bank lowering its target price to GBX 5,555 and maintaining a "hold" rating, while Royal Bank of Canada raised its target to GBX 6,000 and set an "outperform" rating.
  • The company's stock has shown a 1-year low of GBX 4,579 and a high of GBX 5,830, with insiders recently selling and buying shares, indicating mixed sentiment from within the company.
  • Interested in Reckitt Benckiser Group? Here are five stocks we like better.

Reckitt Benckiser Group (LON:RKT - Get Free Report)'s stock had its "buy" rating reaffirmed by equities researchers at UBS Group in a note issued to investors on Friday,Digital Look reports. They currently have a GBX 7,700 target price on the stock. UBS Group's target price would suggest a potential upside of 32.26% from the company's current price.

A number of other analysts have also weighed in on RKT. Berenberg Bank decreased their target price on shares of Reckitt Benckiser Group from GBX 5,920 to GBX 5,555 and set a "hold" rating on the stock in a report on Wednesday, August 6th. Royal Bank Of Canada increased their price target on shares of Reckitt Benckiser Group from GBX 5,700 to GBX 6,000 and gave the stock an "outperform" rating in a report on Thursday, July 24th. Jefferies Financial Group reissued a "hold" rating and issued a GBX 5,200 price target on shares of Reckitt Benckiser Group in a report on Thursday, October 2nd. Finally, Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a GBX 5,300 price target on shares of Reckitt Benckiser Group in a report on Monday, July 21st. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of GBX 5,951.

View Our Latest Analysis on Reckitt Benckiser Group

Reckitt Benckiser Group Stock Performance

Reckitt Benckiser Group stock opened at GBX 5,822 on Friday. The firm's 50 day simple moving average is GBX 5,624.04 and its 200 day simple moving average is GBX 5,238.67. The company has a current ratio of 0.69, a quick ratio of 0.46 and a debt-to-equity ratio of 110.26. The firm has a market capitalization of £39.34 billion, a PE ratio of 3,198.90, a price-to-earnings-growth ratio of 1.10 and a beta of 0.09. Reckitt Benckiser Group has a 1-year low of GBX 4,579 and a 1-year high of GBX 5,830.

Reckitt Benckiser Group (LON:RKT - Get Free Report) last posted its earnings results on Thursday, July 24th. The company reported GBX 141.20 earnings per share for the quarter. Reckitt Benckiser Group had a net margin of 10.78% and a return on equity of 18.70%. As a group, analysts expect that Reckitt Benckiser Group will post 331.2110727 earnings per share for the current fiscal year.

Insider Activity

In other Reckitt Benckiser Group news, insider Shannon Eisenhardt sold 1,798 shares of the firm's stock in a transaction on Friday, August 1st. The shares were sold at an average price of GBX 5,654, for a total value of £101,658.92. Also, insider Tamara Ingram purchased 293 shares of the business's stock in a transaction on Wednesday, July 30th. The stock was purchased at an average cost of GBX 5,626 per share, for a total transaction of £16,484.18. Insiders acquired 2,212 shares of company stock worth $12,488,849 in the last quarter. Insiders own 0.42% of the company's stock.

Reckitt Benckiser Group Company Profile

(Get Free Report)

At Reckitt, we protect, heal and nurture. We are the company behind some of the world's best known and most trusted Health and Hygiene consumer brands. Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years. We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide. At Reckitt, we're all making a real difference to people all over the world, every day.

See Also

Analyst Recommendations for Reckitt Benckiser Group (LON:RKT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Reckitt Benckiser Group Right Now?

Before you consider Reckitt Benckiser Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.

While Reckitt Benckiser Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.